It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The effect of helmet use on reducing the risk of death in cyclists appears to be distorted by some variables (potential confounders, effect modifiers, or both). Our aim was to provide evidence for or against the hypothesis that cycling area may act as a confounder and effect modifier of the association between helmet use and risk of death of cyclists involved in road crashes. Data were analysed for 24,605 cyclists involved in road crashes in Spain. A multiple imputation procedure was used to mitigate the effect of missing values. We used multilevel Poisson regression with province as the group level to estimate the crude association between helmet use and risk of death, and also three adjusted analyses: (1) for cycling area only, (2) for the remaining variables which may act as confounders, and (3) for all variables. Incidence–density ratios (IDR) and their 95% confidence intervals were calculated. Crude IDR was 1.10, but stratifying by cycling area disclosed a protective, differential effect of helmet use: IDR = 0.67 in urban areas, IDR = 0.34 on open roads. Adjusting for all variables except cycling area yielded similar results in both strata, albeit with a smaller difference between them. Adjusting for cycling area only yielded a strong association (IDR = 0.42), which was slightly lower in the adjusted analysis for all variables (IDR = 0.45). Cycling area can act as a confounder and also appears to act as an effect modifier (albeit to a lesser extent) of the risk of cyclists’ death after a crash.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Granada, Department of Preventive Medicine and Public Health, School of Medicine, Granada, Spain (GRID:grid.4489.1) (ISNI:0000000121678994)
2 University of Granada, Department of Preventive Medicine and Public Health, School of Medicine, Granada, Spain (GRID:grid.4489.1) (ISNI:0000000121678994); Centre for Biomedical Research in Network of Epidemiology and Public Health (CIBERESP), Madrid, Spain (GRID:grid.466571.7) (ISNI:0000 0004 1756 6246); Health Research Institute of Granada (Instituto Biosanitario de Granada, ibs.GRANADA), Granada, Spain (GRID:grid.507088.2)
3 University of Granada, Department of Preventive Medicine and Public Health, School of Medicine, Granada, Spain (GRID:grid.4489.1) (ISNI:0000000121678994); University General Hospital, Cardiology Service, Ciudad Real, Spain (GRID:grid.4489.1)
4 University of Granada, Department of Preventive Medicine and Public Health, School of Medicine, Granada, Spain (GRID:grid.4489.1) (ISNI:0000000121678994); Health Research Institute of Granada (Instituto Biosanitario de Granada, ibs.GRANADA), Granada, Spain (GRID:grid.507088.2)